Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sander W Tas

Showing results (11-20 of 141) with videos related to

Pageof 15
Sort By:
The Lancet. Rheumatology|December 19, 2025
Oral glucocorticoid pulse therapy: a modest change in clinical practice with major benefitsLaura C M Schenning, Marieke van Onna, Sander W Tas
Nature Reviews. Rheumatology|December 4, 2015
Targeting of proangiogenic signalling pathways in chronic inflammationSander W Tas, Chrissta X Maracle, Emese Balogh, et al.
The Journal of Experimental Medicine|December 11, 2019
Type-I interferons in atherosclerosisHung-Jen Chen, Sander W Tas, Menno P J de Winther
Current Gene Therapy|June 13, 2009
Gene therapy targeting nuclear factor-kappaB: towards clinical application in inflammatory diseases and cancerSander W Tas, Margriet J B M Vervoordeldonk, Paul P Tak
Autoimmunity Reviews|July 15, 2022
Extrathymic AIRE-expressing cells: Friends or foes in autoimmunity and cancer?Gustaaf G van Laar, Jan Piet van Hamburg, Sander W Tas
Nederlands Tijdschrift Voor Geneeskunde|December 5, 2013
[Off-label use of biologics for rare immunological disorders]Anne Musters, Amira Assaf, Dominique L P Baeten, et al.
Annals of the Rheumatic Diseases|February 5, 2024
An ulcerating skin tumour in a patient with rheumatoid arthritisLaura C M Schenning, Rosanne Ottevanger, Koen D Quint, et al.
European Journal of Clinical Investigation|March 5, 2015
The contribution of NF-κB signalling to immune regulation and toleranceMyrthe A M van Delft, Leonie F A Huitema, Sander W Tas
BMJ Case Reports|October 31, 2015
Anti-interleukin 6 receptor therapy for hyper-IgD syndromeAnne Musters, Paul Peter Tak, Dominique L P Baeten, et al.
European Journal of Immunology|October 31, 2022
Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approachesAna Merino-Vico, Giulia Frazzei, Jan Piet van Hamburg, et al.
Pageof 15

Showing results (11-20 of 141) with videos related to

Sort By:
Pageof 15
The Lancet. Rheumatology|December 19, 2025
Oral glucocorticoid pulse therapy: a modest change in clinical practice with major benefitsLaura C M Schenning, Marieke van Onna, Sander W Tas
Nature Reviews. Rheumatology|December 4, 2015
Targeting of proangiogenic signalling pathways in chronic inflammationSander W Tas, Chrissta X Maracle, Emese Balogh, et al.
The Journal of Experimental Medicine|December 11, 2019
Type-I interferons in atherosclerosisHung-Jen Chen, Sander W Tas, Menno P J de Winther
Current Gene Therapy|June 13, 2009
Gene therapy targeting nuclear factor-kappaB: towards clinical application in inflammatory diseases and cancerSander W Tas, Margriet J B M Vervoordeldonk, Paul P Tak
Autoimmunity Reviews|July 15, 2022
Extrathymic AIRE-expressing cells: Friends or foes in autoimmunity and cancer?Gustaaf G van Laar, Jan Piet van Hamburg, Sander W Tas
Nederlands Tijdschrift Voor Geneeskunde|December 5, 2013
[Off-label use of biologics for rare immunological disorders]Anne Musters, Amira Assaf, Dominique L P Baeten, et al.
Annals of the Rheumatic Diseases|February 5, 2024
An ulcerating skin tumour in a patient with rheumatoid arthritisLaura C M Schenning, Rosanne Ottevanger, Koen D Quint, et al.
European Journal of Clinical Investigation|March 5, 2015
The contribution of NF-κB signalling to immune regulation and toleranceMyrthe A M van Delft, Leonie F A Huitema, Sander W Tas
BMJ Case Reports|October 31, 2015
Anti-interleukin 6 receptor therapy for hyper-IgD syndromeAnne Musters, Paul Peter Tak, Dominique L P Baeten, et al.
European Journal of Immunology|October 31, 2022
Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approachesAna Merino-Vico, Giulia Frazzei, Jan Piet van Hamburg, et al.
Pageof 15